Influence
June 17, 2021

Regenstrief CEO discusses real-world evidence and health services research at AcademyHealth conference

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., participated in a plenary presentation on the changing nature of health-related evidence at the AcademyHealth Annual Research Meeting. He contributed to the discussion about how the addition of healthcare data and artificial intelligence is shifting the generation and application of evidence to improve health and healthcare.  

The speakers examined where real-world evidence meets health services research and discussed how data can be made relevant, contextualized and fit for the purposes of decision making in multiple contexts. They hope to see faster innovation that leads to continued evidence generation and benefits for patients.  

Some of the subjects covered included the use of synthetic data and the need to continuously monitor and evaluate AI algorithms, a process Dr. Embi coined as “algorithmovigilance.” 

Dr. Embí is an internationally recognized leader in the field of clinical and translational research informatics. Artificial intelligence and learning health systems are two of his areas of expertise; both help to turn real-world data into real-world evidence and apply it to improve healthcare.  

Also on the panel were Tanish Carino, PhD of Alexion; Carolyn Magill, MBS of Aetion and Amy Abernathy, M.D., PhD, formerly of the U.S. Food and Drug Administration.  

At the AcademyHealth Annual Research Meeting, health services researchers, policy analysts, clinicians and community members who use evidence and data to transform health and healthcare convene to connect, reflect and learn. 2021’s event was virtual due to the pandemic.  

As part of the conference, Regenstrief and Indiana University Richard M. Fairbanks School of Public Health at IUPUI Research Scientist Nir Menachemi, PhD, MPH, was honored with the Health Services Research Impact Award, in part for his leadership of the first and largest statewide random sample testing study for COVID-19, which generated breakthrough knowledge about the virus.  

About Peter Embí, M.D., M.S.

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health.  

Related News

Eric Vachon, PhD, RN

Study explores how relationship with partner impacts breast cancer survivor’s emotional and physical well-being

Satisfaction with relationship and better agreement are linked with positive health outcomes Diagnosis and treatment of breast cancer places

Kathleen Unroe, M.D. and Gail Towsley, PhD

Improving dementia care in nursing homes: Learning from the pandemic years

No one associated with nursing homes – as residents or their families, friends, staff or administrators – is unaware

Shaun Grannis and Brian Dixon

COVID-19 vaccination as effective for adults with common mental disorders as for those without

Unvaccinated individuals with mental illness have higher rate of hospitalization INDIANAPOLIS – A large multi-state electronic health record-based study